Genentech Company Updates | Glassdoor.com.au

Company Updates

  • Congratulations to Dr. Sandra Horning for being selected as Healthcare Businesswomen’s Association Woman of the Year! During her decade-long tenure with Roche and Genentech, she helped bring 15 new medicines to patients and worked to tackle some of the world’s toughest diseases. We're thankful for her incredible contributions to medicine & to our employees who have been inspired by her commitment to science, patients & women in leadership.

  • Why are scientists excited about biomarkers and big data? In S3E05 of our podcast, David Shames and Mark Lee explain how big data approaches could potentially aid in delivering more personalized care to patients.

  • This week marks Merone Roose-Girma’s 20th anniversary at Genentech. Learn about her journey and passion for mentoring other women of color who want to bring their authentic selves to work. #WomenOfGenentech

  • Sabbaticals have become part of our culture—where every full-time employee has the opportunity to take six weeks of paid time off every six years. It’s a perk that goes beyond just our employees because many are using their time to benefit their families, communities, co-workers and people around the world.

  • It took a village in Venezuela to make the discovery that would change the future of research in Huntington’s disease (HD), a rare, neurological disorder. Learn more about the global collaboration among scientists, HD families and industry partners that has helped advance research in HD. http://glassdoor.com/slink.htm?key=vMLnd

  • Before personalized healthcare entered the recent spotlight, our teams emphasized using insights from biomarkers to inform development of potential new treatments. Read about Heleen Scheerens, Global Head of OMNI-Biomarker Development, whose unique voice is helping propel this science forward to bring better medicines to those who need them. http://glassdoor.com/slink.htm?key=vMuzW

  • http://glassdoor.com/slink.htm?key=vMHmO

  • http://glassdoor.com/slink.htm?key=vMHF4

  • http://glassdoor.com/slink.htm?key=vMRWr

  • As Vice President, Small Molecule Discovery Chemistry, Dan Sutherlin oversees teams that are using new technologies and approaches to target proteins that were previously thought to be impossible to target. In our latest 'Portraits in Science,' learn more about Dan and what inspires his work. http://glassdoor.com/slink.htm?key=vMRXo

    At first, Dan worked as a scientist focused on combinatorial chemistry, a field that was generating a lot of excitement at the time for its ability to rapidly create hundreds of new compounds in parallel. When the field moved forward, however, so did his approach to small molecule discovery.

    At first, Dan worked as a scientist focused on combinatorial chemistry, a field that was generating a lot of excitement at the time for its ability to rapidly create hundreds of new compounds in parallel. When the field moved forward, however, so did his approach to small molecule discovery.

Work at Genentech? Share Your Experiences

Genentech
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or